Chronic lipopolysaccharide (LPS) exposure to mice reduces the lymphoid compartment and skews the hematopoietic cell compartment toward myeloid-cells, which is considered to be a direct effect of LPS on hematopoietic stem cells. However, the effect of chronic LPS exposure on stromal-cells, which compose the hematopoietic microenvironment, has not been elucidated. Here, we investigated early-and late-phase effects of repeated LPS exposure on stromal-cells. During the early phase, when mice were treated with 5 or 25 µg LPS three times at weekly intervals, the numbers of myeloid-progenitor (colony forming unit-granulocyte macrophage (CFU-GM)) cells and B lymphoid-progenitor (CFU-preB) cells in the bone-marrow (BM) rapidly decreased after each treatment. The number of CFU-GM cells recovered from the initial decrease and then increased to levels higher than pretreatment levels, whereas the number of CFU-preB cells remained lower than pretreatment levels. In the BM, expression of genes for positive-regulators of myelopoiesis including granulocyte colony-stimulating factor (G-CSF), granulocyte macrophage colony-stimulating factor (GM-CSF), and interleukin (IL)-6 and negative-regulators of B lymphopoiesis including tumor necrosis factor (TNF)-α was up-regulated, whereas expression of positive-regulators of B lymphopoiesis including stromal cell-derived factor (SDF)-1, IL-7, and stem cell factor (SCF) was down-regulated. During the late phase, the number of CFU-preB cells remained lower than pretreatment levels 70 d after the first treatments with 5 and 25 µg LPS, whereas the number of CFU-GM cells returned to pretreatment levels. IL-7 gene expression in the BM remained down-regulated, whereas gene-expression levels of SDF-1 and SCF were restored. Thus, chronic LPS exposure may impair stromal-cell function, resulting in prolonged suppression of B lymphopoiesis, which may appear to be senescence similar to the hematological phenotype.Key words hematopoiesis; stromal cell; inflammation; cytokine; local regulation Inflammation and infection alter hematopoiesis output of bone marrow (BM) by favoring myelopoiesis, especially granulopoiesis, over B lymphopoiesis.1,2) Lipopolysaccharide (LPS), a major cell wall component of Gram-negative bacteria, induces inflammation via Toll-like receptor (TLR) 4 expressed on the cell surface. In the BM, TLR4 is expressed not only on hematopoietic cells, but also on non-hematopoietic cells such as stromal cells. Thus, LPS is a useful agent to study how hematopoiesis is regulated by stromal cells during inflammation and infection.A single injection of LPS in mice augments myelopoiesis and suppresses B lymphopoiesis, which is similar to the phenomenon observed in mice during inflammation and infection. In the BM, hematopoietic stem cells and hematopoietic progenitor cells are regulated by positive and negative factors produced by stromal cells. 3,4) This reciprocal regulation of myelopoiesis and B lymphopoiesis after LPS treatment is likely an indirect effect via stromal cells rather than a dire...